Stage IIIB Breast Cancer Active Not Recruiting Phase 2 Trials for Eribulin (DB08871)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01372579Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer PatientsTreatment